bluedoor data·H-1B Jobs API·bluedoor.sh ->

Home / Companies / Ocim Pharmaceuticals Llc / Trends

Ocim Pharmaceuticals Llc H-1B trends

Quarterly LCA aggregate trend points for Ocim Pharmaceuticals Llc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.

Summary

H-1B LCA filings for Ocim Pharmaceuticals Llc span 2022 Q4 to 2025 Q3, peaking at 3 filings in 2024 Q4.

The most recent reported period (2025 Q3) shows 2 filings.

LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.

PeriodLCA countRole titlesSOC codesAvg wage lowAvg prevailingCertifiedCertification rate
2022 Q4111$100,000$98,4261100.0%
2023 Q4111$62,000$60,9021100.0%
2024 Q3111$60,902$60,9021100.0%
2024 Q4331$89,333$85,7033100.0%
2025 Q3221$89,543$89,3672100.0%

Frequently asked questions

How have H-1B filings for Ocim Pharmaceuticals Llc changed over time?
H-1B LCA filings for Ocim Pharmaceuticals Llc span 2022 Q4 to 2025 Q3, peaking at 3 filings in 2024 Q4. The most recent reported period (2025 Q3) shows 2 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API

Rendered from the bluedoor H-1B Jobs API. Reproduce it:

GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=ocim+pharmaceuticals+llc&metric=lca_countJSON